Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Major Program

Phase 0 I II Cancer Prevention Clinical Trials Program

Research Group

Gastrointestinal and Other Cancers

Status

Active, not recruiting

NCT ID

NCT02965703

This phase IIa trial studies how well aspirin works in preventing colorectal cancer in patients with colorectal adenoma. Aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Intervention

Aspirin, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Rectal Biopsy

Condition

Colorectal Adenoma, Colorectal Carcinoma

Investigators

Qi Dai

See list of participating sites